Based on new research, men with localized prostate cancer but at high risk for metastasis, have better outcomes if they are treated with radiation combined with androgen deprivation therapy which decreases testosterone, thus reducing chance for tumor spread and growth. Read the article.
Higher doses of radiotherapy control localized prostate cancer (PCa) more effectively than lower doses 10 years after treatment and reduced the need for follow-up androgen-deprivation therapy, according to investigators. Read the article.
More Intensive Radiation May Be Best for Prostate Cancer Read More »
An Interview with Frank Critz, MD Some may find it surprising that Frank A. Critz, MD—a radiation oncologist who focuses on prostate cancer—generally considers radical prostatectomy to be the go-to treatment for localized disease. But now that he and fellow investigators have completed a 25-year study showing radiation therapy outcomes to be equal to those of radical prostatectomy under the strict surgical definition of prostate cancer control (The Journal of Urology 2013;189[3]: 878-883), Dr. Critz—the founder and medical director of Radiotherapy Clinics of Georgia–Decatur (an affiliate of Vantage Oncology), can comfortably recommend both options to patients. Read the article. (Free
PCa Control Similar with Radiation, Radical Surgery Read More »
Men with intermediate or high-risk localised prostate cancer should be given a combination of radical radiotherapy and androgen deprivation therapy, rather than radical radiotherapy or androgen deprivation therapy alone, recommends newly updated guidance [publications.nice.org.uk] from the National Institute of Health and Care Excellence (NICE), published today. Read the article.
Combine treatment for moderate to high risk prostate cancer Read More »
Patients enduring the excruciating pain of cancer that has spread to the bones are often given multiple doses of radiation. There is strong evidence, however, that one dose controls pain as effectively as 10 or more. In addition, one treatment is cheaper and far more convenient for patients who already have plenty on their minds. Read the Article.
Evidence says less may be more when it comes to radiation for bone metastases Read More »
November 2012 Awareness Night “Radiation Therapy for Prostate Cancer in 2012 and beyond.” Dr. Padrick Warde, MD, MCChB BAO, FRCPC Professor, Department of Radiation Oncology, University of Toronto Staff Radiation Oncologist, The Princess Margaret Cancer Centre/University Health Network Associate Director, Radiation Medicine Program, The Princess Margaret Cancer Centre CLICK ON THE ARROW TO START THE VIDEO Complete Presentation “Radiation Therapy for Prostate Cancer in 2012 and beyond.” High Definition 49inutes Click here to return to top. Click here to return to our main “Videos” page.
VIDEO: Dr. Padrick Warde, “Radiation Therapy for Prostate Cancer in 2012 and beyond.” Read More »
Patients with organ-confined prostate cancer may have a new treatment option using high doses of focused stereotactic body radiotherapy (SBRT) instead of traditional lengthy radiotherapy courses or surgery, according to new data presented at the American Society for Radiation Oncology annual meeting. Read More.
One-Week Radiotherapy Course An Option for Localized PCa Read More »